March 24, 2026

ECOG-ACRIN study finds inferior survival among Black patients with AML, independent of cytogenetic risk

February 27, 2026

Attention medical and research trainees: Applications are now being accepted for the Edith Peterson Mitchell, MD, Health Equity Travel Scholarship to attend the Spring 2026 Group Meeting

February 9, 2026

Natasha Edwin, MD, community co-chair of the ECOG-ACRIN Myeloma Committee, highlights why patients in rural areas need access to quality clinical trials

February 3, 2026

ECOG-ACRIN legacy lung cancer studies E1594 and E5508 cited in ASCO Living Guideline 2026.3.0, therapy for stage 4 NSCLC without driver alterations

January 29, 2026

Press Release: New England Journal of Medicine publishes phase 3 PATINA (PrECOG PrE0111) trial data demonstrating a significant progression-free survival benefit with palbociclib in metastatic HR+, HER2+ breast cancer

January 21, 2026

ECOG-ACRIN study identifies high rates of vulnerability in AML patients aged 60 years or older

January 8, 2026

WATCH: Drs. Jen Specht and Heather Jacene discuss the FEATURE (EA1183) trial results…a game-changer for bone-dominant metastatic breast cancer

January 8, 2026

AI models advance individualized breast cancer recurrence risk assessments

January 8, 2026

Caris, cooperative groups advancing AI models that can improve breast cancer risk assessments (access requires free registration)

ECOG-ACRIN Cancer Research Group